SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 153 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,482,473 | -11.8% | 150,626 | 0.0% | 0.02% | -13.8% |
| Q2 2023 | $3,949,414 | +1350.7% | 150,626 | +1210.9% | 0.03% | +1350.0% |
| Q1 2023 | $272,242 | -93.5% | 11,490 | -92.9% | 0.00% | -92.9% |
| Q4 2022 | $4,216,257 | -8.8% | 162,109 | 0.0% | 0.03% | -15.2% |
| Q3 2022 | $4,625,000 | +15.9% | 162,109 | 0.0% | 0.03% | 0.0% |
| Q2 2022 | $3,991,000 | -56.4% | 162,109 | 0.0% | 0.03% | -46.8% |
| Q1 2022 | $9,149,000 | -14.5% | 162,109 | -6.1% | 0.06% | -8.8% |
| Q4 2021 | $10,695,000 | +19.7% | 172,556 | +22.5% | 0.07% | +11.5% |
| Q3 2021 | $8,935,000 | -23.0% | 140,834 | 0.0% | 0.06% | -22.8% |
| Q2 2021 | $11,606,000 | +22.6% | 140,834 | +3.6% | 0.08% | 0.0% |
| Q1 2021 | $9,466,000 | -3.9% | 135,879 | -0.0% | 0.08% | +1.3% |
| Q4 2020 | $9,855,000 | – | 135,880 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |